WINDLAS — Windlas Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹16.80bn
- IN₹14.36bn
- IN₹9.04bn
Annual cashflow statement for Windlas Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 456 | 570 | 771 | 798 | 870 |
| Depreciation | |||||
| Non-Cash Items | -18.9 | -44.7 | -63.8 | -89.1 | 68.5 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -467 | -39.7 | 248 | -306 | -196 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 91.3 | 610 | 1,090 | 682 | 1,049 |
| Capital Expenditures | -148 | -709 | -377 | -522 | -677 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,398 | 568 | -544 | -219 | -241 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,546 | -141 | -921 | -741 | -918 |
| Financing Cash Flow Items | -92 | -19.2 | -11.1 | 0.44 | -7.82 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,301 | -437 | -153 | 10.1 | -130 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -154 | 31.2 | 16 | -48.6 | 1.11 |